Scotland woke up to a sharp debate on November 13. Analysts and watchdogs say a rising tax burden under the Scottish National Party helped create a roughly £1 billion revenue gap. The debate mixes numbers, politics, and real pain for households.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
PayPal Holdings, Inc. (PYPL) is set to release its Q3 2025 results on October 28, 2025. Wall Street is keenly watching, with expectations pointing to around $8.2 billion in revenue and roughly $1.21 in earnings per share. Continue Reading on Meyka This article is available in full on our main platform. Get access to complete…
The Chase Sapphire Reserve just got more hotel-forward, and frequent travelers are taking notice. Chase has redesigned hotel benefits to give cardholders more flexible credits, complimentary elite perks, and better chances at room upgrades. Continue Reading on Meyka This article is available in full on our main platform. Get access to complete analysis, stock insights,…
On October 2025, the RBL Bank share price shocked the market by jumping 5% in a single day, hitting a fresh 52-week high. The sudden rally was not random. It came after reports that Emirates NBD, one of the largest banks in the Middle East, is planning to buy up to 60% stake in RBL…
Khaby Lame is no longer just the silent king of TikTok. The creator who once made people laugh with simple hand gestures and calm facial expressions has now turned viral fame into a serious business success story. His journey from posting short videos to leading a company valued close to $975 million has become one…
The financial future of Thames Water is entering a critical phase. The UK largest water utility is closing in on a £16bn rescue deal, a plan designed to keep taps running and avoid a collapse that could shake the wider economy. Yet this rescue comes with a heavy price. Creditors are bracing for losses of…
Agilent Technologies delivered impressive third-quarter results that exceeded Wall Street expectations. The company raised its full-year revenue forecast based on strong demand across its life sciences portfolio. This positive development signals robust growth in the medical technology sector within the broader stock market. Continue Reading on Meyka This article is available in full on our…